BiotechTube
Home/Pipeline/BCMA panCAR (via Orna partnership)

BCMA panCAR (via Orna partnership)

Multiple Myeloma

PreclinicalActive

Key Facts

Indication
Multiple Myeloma
Phase
Preclinical
Status
Active
Company
Simnova Biotherapeutics

About Simnova Biotherapeutics

Clinical-stage biotech developing off-the-shelf CAR-NK and BiTE CAR-T therapies for cancer treatment.

View full company profile

Therapeutic Areas

Oncology

Other Multiple Myeloma Drugs

DrugCompanyPhase
PRG1801 (Anti-BCMA CAR-T)Pregene BiopharmaPhase 1
CAR-NK TherapyPregene BiopharmaPhase 1
TasquinimodActive BiotechPreclinical
BCMA CAR-TSimnova BiotherapeuticsPhase 1
Measovir®-based candidateOncovitaPre-clinical
Kyprolis® (carfilzomib)Cleo Life SciencesApproved
inobrodib (CCS1477)CellCentricPhase 1/2
ISB 2001Ichnos Glenmark InnovationPhase 1b
In Vivo Cell TherapyGigaMunePre-clinical
HemadyDexcel Pharma USAApproved
AV-353AVEO OncologyPre-clinical
Sequesta™ID4PharmaPre-clinical